Poly(lactic acid) is under investigation in clinical trial NCT00126308 (Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy).
Sanofi-Aventis Administrative Office, Québec, Canada
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.